SYDNEY, Nov. 13, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage Australian biotech, is pleas...
SYDNEY, Aug. 9, 2023 /PRNewswire/ -- Race Oncology Limited ("Race") is pleased to provide a strateg...
* HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop ...
* Race Oncology executes agreement with leading global contract development and manufacturing org...
* Race Oncology executes agreement with leading global contract development and manufacturing org...
* Race executes worldwide license agreement with City of Hope, one of the largest cancer research...
* Race executes worldwide license agreement with City of Hope, one of the largest cancer research...
* Significant improvement in Overall Response Rate (83%) compared with matched case control group...
* INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent ac...
BRISBANE, Australia, May 31, 2023 /PRNewswire/ -- QBiotics Group Limited ( QBiotics), a clinical sta...
SYDNEY, March 28, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage biotech company developing ...
MELBOURNE, Australia, Nov. 15, 2022 /PRNewswire/ -- Australian mid-clinical stage antiviral drug de...
* Investigational new drug (IND) approval received by QBiotics, to initiate a Phase II clinical t...
* Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX's Board of Directors as Non-Executive D...
* New Board appointment deepens and consolidates Servatus' extensive commercial and scientific ex...
SYDNEY, March 28, 2022 /PRNewswire/ -- Sydney-based boutique investor and public relations consulta...
* Study to look at the link between the gut microbiome and sleep, by treating patients who suffer...
* Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma d...
Highlights: * XPON Technologies set to trade on the ASX today from 12.00 PM AEDT * Oversubscrib...
* QBiotics commences the Australian commercial launch of its lead veterinary drug, STELFONTA®, wh...
